Accession Number: | 0001209191-20-013034 |
Date: | 2020-02-24 |
Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Original Submission Date: |
SACHDEV AMIT
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-24 | F | 3,156 | d | $239.23 | 36,291 | direct | ||
COMMON STOCK | 2020-02-25 | S | 953 | d | $230.00 | 35,338 | direct | ||
COMMON STOCK | 2020-02-25 | S | 270 | d | $230.98 | 35,068 | direct | ||
COMMON STOCK | 2020-02-25 | S | 450 | d | $232.62 | 34,618 | direct | ||
COMMON STOCK | 2020-02-25 | S | 90 | d | $233.18 | 34,528 | direct | ||
COMMON STOCK | 2020-02-25 | S | 533 | d | $234.56 | 33,995 | direct | ||
COMMON STOCK | 2020-02-25 | S | 360 | d | $235.75 | 33,635 | direct | ||
COMMON STOCK | 2020-02-25 | S | 180 | d | $236.63 | 33,455 | direct | ||
COMMON STOCK | 2020-02-25 | S | 540 | d | $238.33 | 32,915 | direct | ||
COMMON STOCK | 2020-02-24 | 0 | $0.00 | 16,190 | indirect | ||||
COMMON STOCK | 2020-02-24 | 0 | $0.00 | 882 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | transaction made pursuant to mr. sachdev's company approved trading plan under rule 10b5-1. |
f2 | open market sales reported on this line occurred at a weighted average price of $230.00 (range $229.52 to $230.31). |
f3 | mr. sachdev undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
f4 | open market sales reported on this line occurred at a weighted average price of $230.98 (range $230.57 to $231.26). |
f5 | open market sales reported on this line occurred at a weighted average price of $232.62 (range $232.06 to $233.05). |
f6 | open market sales reported on this line occurred at a weighted average price of $234.56 (range $234.27 to $234.66). |
f7 | open market sales reported on this line occurred at a weighted average price of $235.75 (range $235.63 to $235.82). |
f8 | open market sales reported on this line occurred at a weighted average price of $238.33 (range $238.16 to $238.54). |